Substantial advances in treatment for chronic hepatitis C and a decline in the number of new infections, were highlighted by a panel convened by the National Institutes of Health (NIH).
Nonetheless, a fourfold increase in persons with chronic hepatitis C infection is projected over the next decade, as a result of unsuspected infection from contaminated blood and blood products, occupational exposure, and injection drug use prior to the advent of routine screening in the early 1990s. These chronic infections are now leading to significant increases in cirrhosis, end-stage liver disease, liver cancer, and are the most common causes of liver transplants.
"However, the good news is that new combination therapies are having a beneficial impact on this disease," noted panel chair Dr. James Boyer, Ensign Professor of Medicine and Director of the Liver Center at Yale University School of Medicine. "In addition, preliminary research indicates that this approach may prove useful in treating important subgroups of patients including children and injection drug users previously ineligible for treatment. Up to now, the majority of studies have focused on what is actually a narrow segment of the patient population. Thus, we still have a lot to learn."
More than 4 million Americans are infected with hepatitis C, and of this group, the majority experience chronic infection, defined as detection of the virus in blood over at least a 6-month period. The hepatitis C virus (HCV) is the most common blood-borne infection, and transmission now occurs primarily by injection drug use, high-risk sexual behaviors and occupational exposures such as accidental needle sticks, and mother-to-infant transmission.
Clinical trials are providing persuasive evidence that treating HCV with a combination of pegylated interferon and ribavirin produces a considerably better sustained viral response (SVR) than monotherapy or standard interferon-ribavirin combinaPage: 1 2 Related medicine news :1
Contact: Kelli Marciel
NIH/Office of the Director
. Progress in cardiovascular disease2
. Progress shown in death rates from four leading cancers decline in overall mortality has slowed3
. Initial Avon/NCI breast cancer research grants awarded in Progress for Patients awards program4
. Progress toward a vaccine to fight cocaine addiction is reported5
. Stress Speeds Progression To AIDS6
. Progress In Cancer-Vaccine Studies: Simpler, Safer Approach Producing Encouraging Results7
. Jefferson Researchers Report Progress In Using Vaccinia-Based Vaccine For Melanoma8
. University Of Pittsburgh Researchers Identify Immune System Process That Could Halt Progress Of Cirrhosis In Humans9
. Experts Meet In Canada To Discuss Vaccine Progress10
. Despite Progress, More Action Needed To Protect Medical Students From Exposure
To Disease Through Accidental Needlesticks, UCSF Study Finds11
. Setbacks To Health Progress In Central America